Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-131X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer ; volume:38 ; number:2 ; day:23 ; month:1 ; year:2021 ; pages:1-10 ; date:2.2021
Medical oncology ; 38, Heft 2 (23.1.2021), 1-10, 2.2021
- Creator
-
Vietri, Maria Teresa
D’Elia, Giovanna
Caliendo, Gemma
Casamassimi, Amelia
Federico, Alessandro
Passariello, Luana
Cioffi, Michele
Molinari, Anna Maria
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12032-021-01454-5
- URN
-
urn:nbn:de:101:1-2021040518552672965706
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vietri, Maria Teresa
- D’Elia, Giovanna
- Caliendo, Gemma
- Casamassimi, Amelia
- Federico, Alessandro
- Passariello, Luana
- Cioffi, Michele
- Molinari, Anna Maria
- SpringerLink (Online service)
Other Objects (12)
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Hereditary Breast and Ovarian Cancer Syndrome (BRCA) Gene: Concept, Pathways, Therapeutics, and Future
The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H/MMR-D endometrial carcinomas
Military medical research : MMR
Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study
Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
10 Jahre MMR – eine subjektive Rückschau
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Hereditary Breast and Ovarian Cancer Syndrome (BRCA) Gene: Concept, Pathways, Therapeutics, and Future
The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H/MMR-D endometrial carcinomas
Military medical research : MMR
Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study
Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
10 Jahre MMR – eine subjektive Rückschau
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Hereditary Breast and Ovarian Cancer Syndrome (BRCA) Gene: Concept, Pathways, Therapeutics, and Future
The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H/MMR-D endometrial carcinomas
Military medical research : MMR
Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study
Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
10 Jahre MMR – eine subjektive Rückschau
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers